Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMXCJP8)

Drug Name

STP1002 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Tankyrase (TNKS)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BGB-290	DMRO6XT	Ovarian cancer	2C73	Phase 2	[3]
2X-121	DMX9MSL	Breast cancer	2C60-2C65	Phase 2	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT04505839) First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors. U.S. National Institutes of Health.
2	Design and development of a tankyrase inhibitor STP06-1002 as an anticancer therapeutic agent. Cancer Res 2017;77(13 Suppl):Abstract nr 5171.
3	National Cancer Institute Drug Dictionary (drug id 769217).
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)